Yoana Dyankova

Yoana Dyankova

Auto-generated profile, based on publicly available information

Yoana Dyankova

Department of Paediatrics, Medical Uiversity of Varna, 1, Blvd Hristo Smirnenski, Varna, Bulgaria

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2021 in ScienceOpen Preprints
Verified
Preprint
Open access
PDF file
AHAdriana Hadzhieva-Hristova
Adriana Hadzhieva-Hristova
MBMartin Boyadzhiev
Martin Boyadzhiev
KGKalina Ganeva
Kalina Ganeva
YDYoana Dyankova
Yoana Dyankova
TKTeodora Karamfilova
Teodora Karamfilova
VIVioleta Iotova
Violeta Iotova
Background Multisystem Inflammatory Syndrome in children related to COVID-19 (MIS-C) is a new condition the aftermath of which is yet to be studied both in Bulgaria and globally. Up to mid December 2020, world COVID-19 fatalities are put at 1 582 674, according WHO statistics. Case Presentation Summary We present a 15 years old patient with MIS-C, diagnosed with acute abdomen, operated andtreated for septic shock syndrome. The current situation represents a major clinical challenge in part due to the complex differential diagnosis involved: acute abdomen, septic shock, autoimmune diseases (Lupus erythematosus, Juvenile idiopathic arthritis, Kawasaki disease, Acquired immune deficiency, Crohn`s disease, Ulcer colitis), acute myocarditis. At the same time, other symptoms observed in children with COVID-19 such as skin rashes, lymphadenopathy, conjunctivitis are not presented inour patient. We did not observe any myocardial injury, however she went into an acute vasodilatory shock with tachycardia, reduced kidney perfusion pressure and oliguria. Learning Points/Discussion Effects of SARS-CoV-2 infection on patients will be a subject of analysis and clinical research. Differential diagnosis of the multisystem inflammation syndrome in children, clinical experience and new therapeutic strategies are the key to reducing mortality and long-term complications in the affected patients.